FLOW CYTOMETRY RESOURCE

  • Ginsberg, Harold S. (PI)
  • Stall, Alan (PI)
  • Siu, Gerald (PI)
  • Klein, Ulf (PI)

Projet

Détails sur le projet

Description

A fully Cancer Center-managed facility, the Flow Cytometry Shared Resource assists HICCC members in flow cytometry-based studies. Services include: ¿ Fluorescence-activated cell sorting (FACS) ¿ Analytical flow cytometry for immunophenotyping ¿ Flow cytometry for analyzing cell cycle and apoptosis The capacity of the facility has increased substantially over the past three years due to the acquisition of new instruments. The facility now operates five instruments, including two fluorescence-activated cell sorters that allow high-speed cell sorting and can detect up to 12 fluorescent parameters, and one advanced cell analyzer that besides multi-color fluorescence is able to perform specialty applications such as determination of DMA content, multiple (living color) fluorescent protein analysis and calcium flux measurements. In addition to those sophisticated instruments, the facility provides access to two useroperated basic cytometers permitting 3 or 4 color immunophenotyping, respectively, as well as cell cycle and apoptosis assays. Over the last several years, the services of the facility have benefited 130 CUMC investigators, with HICCC members comprising the main users of the instruments accounting for ~60%. The high usage volume allows the facility to offer the services at low fees, which are further reduced for HICCC members. The sophisticated equipment available in the facility allows investigators at Columbia to perform state-of-the-art research in the area of flow cytometry, and therefore represent a vital resource for HICCC members. In the future, we plan to upgrade the flow cytometers to facilitate detection and sorting of newly developed living color fluorescent proteins and to purchase an instrument that serves as a flexible analysis platform for additional fluorescence-based techniques, including cytometric bead assays (CBA) to measure cytokine production, among other potential applications. During the last period of the CCSG, 36% of the investigators using the facility were Cancer Center members with peer-reviewed funding, with those members representing from 50% to 66% of the usage of the 3 available services. The proposed total operating budget of the facility is $425,004, of which we are requesting $ 116,271 from the CCSG
StatutTerminé
Date de début/de fin réelle10/1/846/30/13

Financement

  • National Cancer Institute: 168 652,00 $ US
  • National Cancer Institute: 147 893,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 167 934,00 $ US
  • National Cancer Institute: 263 834,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 296 752,00 $ US
  • National Cancer Institute: 165 134,00 $ US
  • National Cancer Institute: 136 392,00 $ US

Keywords

  • Bioquímica, genética y biología molecular (todo)
  • Biología celular
  • Medicina (todo)

Empreinte numérique

Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.
  • Cancer Center Support Grant

    Rustgi, A. (PI), Chung, W. (PI), Floratos, A. (PI), Hu, J. (PI), Pon, L. (PI), Crew, K. (PI), Creusot, R. (PI), Costantini, F. (PI), Couronne, O. (PI), Zha, S. (PI), Hibshoosh, H. (PI), Soni, R. K. (PI), Gautier, J. (PI), Shen, M. (PI), Hershman, D. L. (PI), Terry, M. B. (PI), Lassman, A. (PI), Fojo, A. T. (PI), Weinstein, B. (PI), Antman, K. (PI), Benson, M. (PI), Dalla-favera, R. (PI), Emerson, S. (PI) & Abate-shen, C. (PI)

    National Cancer Institute

    1/1/906/30/22

    Projet